Evidence map›Paper›PMID 38544982›Full record

ArticleFrontiers in bioengineering and biotechnology2024

A GMR enzymatic assay for quantifying nuclease and peptidase activity.

Michael Sveiven, Ana K Serrano, Joshua Rosenberg, Douglas J Conrad, Drew A Hall, Anthony J O'Donoghue

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael SveivenDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, United States.
Ana K SerranoSchool of Biological Sciences, University of California, San Diego, La Jolla, CA, United States.
Joshua RosenbergDepartment of Electrical and Computer Engineering, University of California, San Diego, La Jolla, CA, United States.
Douglas J ConradDepartment of Medicine, University of California, San Diego, La Jolla, CA, United States.
Drew A HallDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, United States.
Anthony J O'DonoghueSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States.
University of California San Diego · USLa Jolla Bioengineering Institute · US

Funding

Point-of-Care Quantitation of Sputum Neutrophil Elastase Activity in Chronic Airway DiseaseR21EB028485 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALL, DREW ALEXANDER, O'DONOGHUE, ANTHONY JOHN · 2019 to 2021
$631k
NIBIB NIH HHS R21 EB028485
6 · The paper itself

Abstract

Hydrolytic enzymes play crucial roles in cellular processes, and dysregulation of their activities is implicated in various physiological and pathological conditions. These enzymes cleave substrates such as peptide bonds, phosphodiester bonds, glycosidic bonds, and other esters. Detecting aberrant hydrolase activity is vital for understanding disease mechanisms and developing targeted therapeutic interventions. This study introduces a novel approach to measuring hydrolase activity using giant magnetoresistive (GMR) spin valve sensors. These sensors change resistance in response to magnetic fields, and here, they are functionalized with specific substrates for hydrolases conjugated to magnetic nanoparticles (MNPs). When a hydrolase cleaves its substrate, the tethered magnetic nanoparticle detaches, causing a measurable shift in the sensor's resistance. This design translates hydrolase activity into a real-time, activity-dependent signal. The assay is simple, rapid, and requires no washing steps, making it ideal for point-of-care settings. Unlike fluorescent methods, it avoids issues like autofluorescence and photobleaching, broadening its applicability to diverse biofluids. Furthermore, the sensor array contains 80 individually addressable sensors, allowing for the simultaneous measurement of multiple hydrolases in a single reaction. The versatility of this method is demonstrated with substrates for nucleases, Bcu I and DNase I, and the peptidase, human neutrophil elastase. To demonstrate a clinical application, we show that neutrophil elastase in sputum from cystic fibrosis patients hydrolyze the peptide-GMR substrate, and the cleavage rate strongly correlates with a traditional fluorogenic substrate. This innovative assay addresses challenges associated with traditional enzyme measurement techniques, providing a promising tool for real-time quantification of hydrolase activities in diverse biological contexts.

Indexed as

disease monitoringDNA substrateenzymatic activitygiant magnetoresistive sensorGMRpeptide substratepoint-of-care testing

Identifiers

PMID38544982
PMCPMC10966768
OpenAlexW4392761494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.